NCPA Updates--April 2009

Published Online: Thursday, April 23, 2009

Make Health Care Reform Work for You and Your Patients!
NCPA's Annual Conference on National Legislation and Government Affairs is shaping up to be one of the best and most important ever. Hear from speakers and others addressing our key legislative issues: health care reform, a Medicaid AMP fix, DME accreditation, and PBM business negotiation rights. Please note this year's schedule: The conference begins at noon on Monday, May 11, and concludes with a pharmacist rally on Wednesday morning, May 13. The Congressional Reception is now Tuesday evening. Get involved! Register today!

Don't Just Dream It, Do It
Register today for the Pharmacy Ownership Workshop, May 1-3, in Pittsburgh, Pennsylvania. Sponsored by Pharmacists Mutual, McKesson, and Rochester Drug, the Pharmacy Ownership Workshop is specifically designed for pharmacists considering pharmacy ownership or desiring additional management skills. More than 50% of past workshop participants now own their own pharmacy. Class size is limited to the first 75 paid registrants, so register early. To register or for more information, click here.

NCPA Members Forum Series
Have you missed the NCPA Members Forum Series? To date, >350 pharmacists have dialed in to the new members-only live discussions on DME accreditation, small business tax provisions, pharmacy security, and the new NCPA Prescription Disposal Program. NCPA members can log on at to download recordings and materials from previous calls.

Join us on April 29 for the next discussion on "The Impact of ARRA [American Recovery and Reinvestment Act of 2009] on Health Information Technology and Privacy Provisions in Retail Pharmacy." For more information on how to register, please provide your full name, pharmacy name, and NCPA member ID via e-mail to Valerie Briggs.

Latest Articles
A pharmacy robber not only left his fingerprints behind at a pharmacy—he also dropped his wallet containing his identification as he made his escape.
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk.
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Latest Issues